logo
Select company
Select metric
$ 420.89MShareholders Equity
VS
Market
53
Sector
78
Industry
86
History
74
$ 9.96Close
$ 2.51 - $ 9.97 52-Week Range
Ticker Information

Ticker

FDMT

Company Name

4D MOLECULAR THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

4D MOLECULAR THERAPEUTICS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FDMT - Equity Historical data
DateShareholders Equity
6/30/2025$ 420.89M
3/31/2025$ 469.72M
12/31/2024$ 510.61M
9/30/2024$ 552.95M
6/30/2024$ 588.34M
3/31/2024$ 600.56M
12/31/2023$ 307.83M
9/30/2023$ 329.93M
6/30/2023$ 325.14M
3/31/2023$ 218.61M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • 4D MOLECULAR THERAPEUTICS INC's latest trailing twelve months (TTM) Equity stands at $ -105.29M.
  • Over the past 5 years, 4D MOLECULAR THERAPEUTICS INC's average Equity has been $ 327.67M.
  • The median Equity for 4D MOLECULAR THERAPEUTICS INC during this period was $ 301.94M
  • 4D MOLECULAR THERAPEUTICS INC reached its highest Equity over the past 5 years at $ 600.56M.
  • The lowest Equity recorded by 4D MOLECULAR THERAPEUTICS INC in the same timeframe $ -105.29M

4D MOLECULAR THERAPEUTICS INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
ALT : ALTIMMUNE INC $ 161.37MLYEL : LYELL IMMUNOPHARMA INC $ 298.92MLXEO : LEXEO THERAPEUTICS INC $ 138.22MNMRA : NEUMORA THERAPEUTICS INC $ 182.88MANNX : ANNEXON INC $ 199.02MDMAC : DIAMEDICA THERAPEUTICS INC $ 27.17MAARD : AARDVARK THERAPEUTICS INC $ 136.93MAVIR : ATEA PHARMACEUTICALS INC $ 364.42MGALT : GALECTIN THERAPEUTICS INC $ -118.89MJBIO : JADE BIOSCIENCES INC $ 201.56M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

FDMT - Shareholders Equity, Last 5 years

$ -105.29M

Minimum

Sep 30, 2020

$ 600.56M

Maximum

Mar 31, 2024

$ 327.67M

Average

$ 301.94M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384.64M with a standard deviation of $ 549.08M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384.64M
median$ 166.2M
std$ 549.08M